UnitedHealth is showing signs of recovery, climbing 70 positions in the past month into the Favoured zone of the SIA S&P 100 Report despite its sector remaining deeply out of favour. A recent Spread Double Top signal suggests improving demand, with the stock now testing resistance near current levels. While short-term momentum has strengthened, its longer-term underperformance relative to the S&P 100 Index suggests this may still be an early-stage rebound.